Aegerion Pharmaceuticals Announces Presentation at the Cowen and Company 33rd
Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals,
Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the
development and commercialization of novel therapeutics to treat debilitating
and often fatal rare diseases, announced today that the company will
participate in the Cowen and Company 33rd Annual Health Care Conference in
Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to
present on Monday, March 4, 2013 at 1:30 p.m. ET.
The presentation will be webcast live and may be accessed for up to 14 days
following the conference by visiting the "Investors" section of Aegerion's
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the
development and commercialization of innovative, life-altering therapies for
patients with debilitating, often fatal, rare diseases. For more information
about the company, please visit www.aegerion.com.
The Aegerion Pharmaceuticals, Inc. logo is available at
CONTACT: Aegerion Pharmaceuticals, Inc.
Manager, Investor Relations
Aegerion Pharmaceuticals, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.